SCHEMBL400412

SCHEMBL400412

CN(C)C(=O)c1cc(CCCC(=O)OCc2ccccc2)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
LMNA P02545 1/20 0.40
CASP1 P29466 1/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.39
RAB9A P51151 2/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL402138 0.83 KMT2A (0.42) ALOX5LMNACASP1ALDH1A1MAPK1
SCHEMBL400213 0.78 CYP4F2 (0.51) ALDH1A1KDM4ECYP3A4HPGDTSHR
SCHEMBL9625116 0.76 MAOB (0.56) ALOX5FAAHMGLLLMNACASP1
SCHEMBL13579886 0.76 PPARG (0.40) ALDH1A1KDM4ERAB9ATP53HPGD
SCHEMBL14368556 0.75 TDP1 (0.61) ALOX5MGLLLMNACASP1ALDH1A1
SCHEMBL3732157 0.75 ALDH1A1 (0.49) ALDH1A1KDM4ECYP3A4HPGDTSHR
SCHEMBL24405140 0.75 TDP1 (0.54) LMNACASP1ALDH1A1MAPK1L3MBTL1
SCHEMBL5065166 0.74 MAOB (0.53) ALOX5L3MBTL1RAB9AKMT2ASMN1; SMN2
SCHEMBL8356503 0.73 MAPK1 (0.51) ALOX5MGLLLMNACASP1ALDH1A1
SCHEMBL14793821 0.73 TRPV1 (0.57) ALOX5FAAHMGLLLMNACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA ALOX5 1129/4885FAAH 394/4885MGLL 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.